NON-PEGYLATED LIPOSOMAL DOXORUBICIN COMBINATIONS FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

摘要

The present invention relates to a method for treating triple-negative metastatic breast cancer in an individual comprising administering to an individual in need thereof a dosing regimen which comprises nonpegylated liposomal doxorubicin, a taxane and a chemotherapeutic agent selected from the group consisting of capecitabine, vinorelbine, gemcitahine, carboplatin, and ixahepilone, and wherein said individual previously has been administered an anthracycline. In some embodiments, the individual is not administered transtuzumab.

主权项

1. A method for treating triple-negative metastatic breast cancer comprising administering to an individual in need thereof a dosing regimen which comprises nonpegylated liposomal doxorubicin and paclitaxel.